As with any medicinal product, the MHRA will keep the safety and effectiveness of the intravesical delivery system containing gemcitabine under close review.
Flavoured noodle products are the most likely source of an ongoing multi-country outbreak of Salmonella Stanley infections, with evidence linking the cases to items from the same brand, according to a Rapid Outbreak Assessment by EFSA and ECDC.
Thousands more people at risk from a virus which causes pneumonia and other serious lung infections will be able to get vital protection on the NHS this winter. From September, all adults aged 65-74 who are living with a chronic respiratory disease and those with immunosuppression due to disease or treatment will be offered the respiratory syncytial virus […]
MRSA, MSSA, Gram-negative bacteraemia infections by organisation and location of onset, and Clostridioides difficile infections (CDI) by organisation and prior trust exposure.
Information on the expansion of the eligibility criteria of the older adults respiratory syncytial virus (RSV) vaccination programme from 1 September 2026.
List of those receiving pre-release access to the monthly UK Health Security Agency mandatory healthcare-associated infections (HCAI) statistical release.
Information to help schools support the delivery of the National Child Measurement Programme to measure children's height and weight in reception and year 6.
Guidance on running the National Child Measurement Programme, which collects the height and weight of reception and year 6 children across England every year.
This Evaluation Strategy sets out UKHSA’s organisation‑wide approach to planning, conducting and using evaluation across science, operations and public health policy.
Provide innovators and developers of innovative products access to MHRA scientific expertise, regulatory guidance and an enhanced advice and signposting service.
The Innovation Accelerator provides innovators and developers of innovative products access to MHRA scientific expertise, regulatory guidance and an enhanced advice and signposting service.
Brancaster Pharma Limited has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification were released with an outdated PIL.